Vignasai Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-01-2025
- Paid Up Capital ₹ 0.10 M
as on 10-01-2025
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 10-01-2025
- Revenue -43.38%
(FY 2022)
- Profit -39.92%
(FY 2022)
- Ebitda -50.17%
(FY 2022)
- Net Worth 24.31%
(FY 2022)
- Total Assets -13.45%
(FY 2022)
About Vignasai Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Pogurieswaraiah, Madhavaiah Chandra, Sahithi Thirumuri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24309TG2016PTC111148
- Company No.
111148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vignasai Laboratories Private Limited offer?
Vignasai Laboratories Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Aldehydes.
Who are the key members and board of directors at Vignasai Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhavaiah Chandra  | Director | 25-Sep-2018 | Current |
| Pogurieswaraiah | Director | 24-Feb-2020 | Current |
| Sahithi Thirumuri | Director | 27-Jul-2016 | Current |
| Mydhili Kolli | Director | 27-Jul-2016 | Current |
| Raja Thirumuri | Director | 25-Sep-2018 | Current |
Financial Performance of Vignasai Laboratories.
Vignasai Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.38% decrease. The company also saw a substantial fall in profitability, with a 39.92% decrease in profit. The company's net worth Soared by an impressive increase of 24.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vignasai Laboratories?
In 2022, Vignasai Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jul 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Vignasai Laboratories?
Unlock and access historical data on people associated with Vignasai Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vignasai Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vignasai Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
